Department of Hematology and Medical Oncology, College of Medicine, Kyung Hee University, Seoul, Korea.
Department of Research and Analysis, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
J Korean Med Sci. 2023 Sep 18;38(37):e299. doi: 10.3346/jkms.2023.38.e299.
Menorrhagia is a common cause of iron deficiency anemia (IDA) in premenopausal women. However, the effects of menorrhagia on IDA in premenopausal women have been underestimated compared to those on other IDA-related disorders (IRDs) such as gastrointestinal malignancies (GIMs). To better understand the relationship between menorrhagia and IDA in premenopausal women, we analyzed the National Health Insurance Service-National Health Information Database (NHIS-NHID).
From 2005 to 2008, data about women between the age of 20 and 59 years were extracted from the NHIS-NHID to create a propensity score-matched case (IDA) and control group. The annual incidence of IDA was calculated per age group. A 10-year follow up of the study population was determined to detect IRDs in case and control groups. We compared the risk of detection (ROD) of IRDs, including GIM and gynecological disorders associated with menorrhagia - leiomyoma of uterus (LM) and adenomyosis (AM), in the case and the control group.
From 2005 to 2008, women diagnosed with IDA (n = 535,249) and healthy women as a control group (n = 1,070,498) were identified from the NHIS-NHID. The annual incidence of IDA was 767.4 (2005), 948.7 (2006), 981.6 (2007), and 897.7 (2008) per 100,000 women. The age distribution of IDA was similar each year; IDA was common in women aged 30-39 years (36-37%) and 40-49 years (30-32%), and its incidence was significantly decreased in women aged 50-59 years (< 10%). The ROD of IRDs were significantly higher in the IDA group than in the control group (LM: 20.8% vs. 6.9%, AM: 5.6% vs. 1.6%, and GIM: 2.6% vs. 0.7%). The corresponding hazard ratios were 3.89 (95% confidence interval [CI], 3.85-3.93) for LM, 4.99 (95% CI, 4.90-5.09) for AM, and 3.43 (95% CI, 3.32-3.55) for GIM. The ROD of the IRDs varied; the ROD of LM in the IDA group increased with age and decreased in the age group 50-59 years. AM was more frequently detected in women with IDA aged 30-39 years and less in women older than 40 years. The frequency of GIM increased with age.
In this study, we found that the gynecologic disease is the main cause of IDA in premenopausal women. Gynecological evaluations should be performed more actively in the clinic to prevent and control IDA and IRDs.
月经过多是绝经前妇女缺铁性贫血(IDA)的常见原因。然而,与胃肠道恶性肿瘤(GIMs)等其他与 IDA 相关的疾病(IRDs)相比,月经过多对绝经前妇女 IDA 的影响被低估了。为了更好地了解月经过多与绝经前妇女 IDA 之间的关系,我们分析了国家健康保险服务-国家健康信息数据库(NHIS-NHID)。
2005 年至 2008 年,从 NHIS-NHID 中提取了年龄在 20 至 59 岁之间的女性数据,以创建倾向评分匹配的病例(IDA)和对照组。按年龄组计算 IDA 的年发病率。确定对研究人群进行 10 年随访,以检测病例和对照组中的 IRD。我们比较了病例组和对照组中包括 GIM 和与月经过多相关的妇科疾病-子宫肌瘤(LM)和子宫腺肌病(AM)在内的 IRD 的风险检出率(ROD)。
2005 年至 2008 年,从 NHIS-NHID 中确定了患有 IDA(n=535,249)的女性和健康女性作为对照组(n=1,070,498)。IDA 的年发病率为每 100,000 名女性中 767.4(2005 年)、948.7(2006 年)、981.6(2007 年)和 897.7(2008 年)。IDA 的年龄分布每年相似;30-39 岁(36-37%)和 40-49 岁(30-32%)的女性 IDA 更为常见,50-59 岁的女性 IDA 发病率显著降低(<10%)。IRD 的 ROD 在 IDA 组明显高于对照组(LM:20.8%比 6.9%,AM:5.6%比 1.6%,GIM:2.6%比 0.7%)。相应的危险比为 3.89(95%置信区间[CI],3.85-3.93)用于 LM,4.99(95%CI,4.90-5.09)用于 AM,3.43(95%CI,3.32-3.55)用于 GIM。IRD 的 ROD 有所不同;IDA 组 LM 的 ROD 随年龄增加而增加,并在 50-59 岁年龄组中降低。30-39 岁的 IDA 女性中 AM 的检出率较高,而 40 岁以上的女性 AM 的检出率较低。GIM 的频率随年龄增加而增加。
在这项研究中,我们发现妇科疾病是绝经前妇女 IDA 的主要原因。应在临床中更积极地进行妇科评估,以预防和控制 IDA 和 IRDs。